AAL vs CGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

AAL

49.4
AI Score
VS
AAL Wins

CGEN

39.5
AI Score

Investment Advisor Scores

AAL

49score
Recommendation
HOLD

CGEN

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAL CGEN Winner
Revenue 54.63B 72.76M AAL
Net Income 111.00M 35.34M AAL
Net Margin 0.2% 48.6% CGEN
Operating Income 1.47B 31.33M AAL
ROE -3.0% 34.4% CGEN
ROA 0.2% 22.6% CGEN
Total Assets 61.77B 156.57M AAL
Cash 954.00M 90.60M AAL
Current Ratio 0.50 6.56 CGEN

Relative Price Performance (Last 90 Days)

AAL 1M: +2.0% · 3M: +1.7% CGEN 1M: +11.8% · 3M: +0.2%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.1 · Price: $13.82

CGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $2.62

Fundamentals Snapshot

Metric AAL CGEN
Market Cap
Forward P/E 5.7 -7.1
Trailing P/E 7.0
Revenue (TTM)
Revenue Growth 0.2% 1.1%
Gross Margin 0.2% 0.9%
Operating Margin 0.0% -3.4%
EPS -0.49 0.38
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.